Article contents
Hypersalivation Associated with Olanzapine and Valproate Combination: A Case Report
Published online by Cambridge University Press: 01 March 2011
Abstract

- Type
- Letters to the Editors
- Information
- Copyright
- Copyright © Cambridge University Press 2012
Footnotes
Faculty Disclosures: Dr. Fernandes is supported by a scholarship from Conselho Nacional de Pesquisa (CNPq), Brazil. Dr. Gama has received grant/research support from CAPES, CNPq, FIPE–HCPA, and Endeavour Award; is a consultant/advisor to and has received consulting fees from Actelion; is on the speaker's bureau of and has received honoraria from AstraZeneca and Lundbeck. Dr. Kieling reports no affiliation with or financial interest in any organization that might pose a conflict of interest. These organization orgaagencies had no role in study design, acquisition and interpretation of data or writing the report.
References
Faculty Disclosures: Dr. Fernandes is supported by a scholarship from Conselho Nacional de Pesquisa (CNPq), Brazil. Dr. Gama has received grant/research support from CAPES, CNPq, FIPE–HCPA, and Endeavour Award; is a consultant/advisor to and has received consulting fees from Actelion; is on the speaker's bureau of and has received honoraria from AstraZeneca and Lundbeck. Dr. Kieling reports no affiliation with or financial interest in any organization that might pose a conflict of interest. These organization orgaagencies had no role in study design, acquisition and interpretation of data or writing the report.
- 1
- Cited by